Professor Dan Aderka

Professor Dan Aderka is an experienced oncologist specializing in the treatment of malignant gastrointestinal tumors. He has more than 30 years of clinical experience, during which he has consulted and treated patients with oncological diagnoses, improving their chances of survival and their health.

Many patients with gastrointestinal tumors who were treated by Dr. Aderka went on to have successful surgery and continued to live. In Israel, Professor Aderka is considered one of the best practicing specialists in the non-surgical treatment of cancer of the stomach, intestine, pancreas and other abdominal organs.

Professor Aderka graduated from the Faculty of Medicine of Tel Aviv University and began his internal medicine residency in 1979 at the Beilinson Medical Center. In 1984, after completing his residency, he was promoted to deputy director of Internal Medicine Department "Tet" (9) at the Tel Aviv Medical Center. In addition to this position, Professor Aderka independently joined the research group of Professor David Wallach at the Weizmann Institute of Science.

From 1987 to 1989, Professor Aderka continued his research at NYU Medical Center in New York. He then returned to his position at the Tel Aviv Medical Center and to his research at the Weizmann Institute. Thanks to his research, 10 international patents have been registered in his name. He has also published about 135 medical articles, some of them in leading scientific journals.

In 1993, Professor Aderka turned to oncology, and from 1998 to 2003 he headed the oncology inpatient department at the Tel Aviv Medical Center. In 2003 he moved to the Sheba Medical Center in order to establish a gastrointestinal tumors department, which became the leading one in its field and the most sought-after in Israel. Professor Aderka currently practices and consults patients at one of the largest public hospitals in Israel.

Alongside innovative treatment methods, Professor Aderka pursues original medical research, takes part in international cancer studies, and represents Israel in the European Society for Medical Oncology (ESMO) as a specialist in the treatment of gastrointestinal tumors.

Today, Professor Dan Aderka, MD, has the status of an internationally recognized specialist and is a recognized authority in the diagnosis and treatment of abdominal tumors. He has written more than 100 scientific papers on the diagnosis and treatment of gastrointestinal cancer, dozens of which have been published in medical journals around the world.

Dan Aderka heads the GI oncology department at Sheba Hospital, which he established in 2003 and which is the most sought-after among similar departments in Israel. Alongside clinical practice, he continues research into the treatment of gastrointestinal tumors, actively takes part in scientific and clinical studies in this field both in Israel and internationally, and constantly looks for new options in the non-surgical treatment of cancer. Professor Aderka is a member of oncology societies and associations in Israel and the USA, and represents Israel in the European Society for Medical Oncology (ESMO) as an expert-level specialist in non-surgical treatment of gastrointestinal cancers.

• Colon and rectal tumors, and treatment to reduce liver and abdominal metastases in preparation for surgery.
• Pancreatic tumors.
• Tumors of the bile ducts and liver (hepatoma, cholangiocarcinoma).
• Tumors of the esophagus, stomach and small intestine.
• Neuroendocrine tumors (carcinoid).
• GIST tumors.
• Tumors of unknown origin.

In treating oncology patients, Dan Aderka uses the most advanced medical technologies, which allows him to achieve high therapeutic results.